Liz KaneImpactful Strategy
David LinetskyPoint-of-Care Marketing
Paul TheisenPatient Acquisition
Suma Ramadas, PhDMedical Affairs
Frank BurrellScientific Storytelling
Brenda SnowAuthentic Patient Voice
Bud BilanichSuccess Coach
Matthew DurhamOmnidynamic Marketing
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Matt TurnerPatient Affordability
Daniel SontupeMarket Access
Pat PurcellMeeting Engagement
Joey CohenMedication Adherence
Phase 1/2 clinical trial combines Regeneron’s PD-1 inhibitor cemiplimab and Inovio’s immunotherapy INO-5401 in ...
Top-line results from the randomized, double-blind confirmatory Phase III study (ERADICATE Hp2 study) with ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email